A MULTICENTER ASSESSMENT OF SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) WHO RECEIVED IMMUNE CHECKPOINT INHIBITOR THERAPY (ICI) WITH OR WITHOUT CYTOREDUCTIVE NEPHRECTOMY (CN)

被引:0
作者
Gross, Evan
Li, Mingjia
Yin, Ming
Orcutt, Delaney
Hussey, Duncan
Trott, Elliot
Kramer, Joel
Oliva, Kaylee
Gore, John
Schade, George
Lin, Daniel
Tykodi, Scott
Hall, Evan
Thompson, John
Parikh, Anish
Yang, Yuanquan
Collier, Katharine
Miah, Abdul
Mori-Vogt, Sherry
Hinkley, Megan
Mortazavi, Amir
Monk, Paul
Folefac, Edmund
Clinton, Steven
Psutka, Sarah
机构
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
MP14-08
引用
收藏
页码:E255 / E255
页数:1
相关论文
共 50 条
[11]   The role of cytoreductive nephrectomy (CN) in the immune checkpoint inhibitor (ICI) era of metastatic renal cell carcinoma (mRCC): A systematic review and individual patient data (IPD) meta-analysis of 2319 patients [J].
Makrakis, Dimitrios ;
Msaouel, Pavlos ;
Karam, Jose A. ;
Esagian, Stepan M. .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) :425-425
[12]   RACIAL DIFFERENCES IN OUTCOMES FOR METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS MANAGED ON IMMUNE-CHECKPOINT INHIBITOR (ICI) THERAPY [J].
Olsen, T. Anders ;
Martini, Dylan ;
Goyal, Subir ;
Liu, Yuan ;
Evans, Sean ;
Magod, Benjamin ;
Brown, Jacqueline ;
Yantorni, Lauren ;
Russler, Greta ;
Caulfield, Sarah ;
Goldman, Jamie ;
Nazha, Bassel ;
Harris, Wayne ;
Master, Viraj ;
Kucuk, Omer ;
Carthon, Bradley ;
Bilen, Mehmet .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 :A133-A133
[13]   Cytoreductive nephrectomy (CN) for patients with metastatic sarcomatoid and/or rhabdoid (S/R) renal cell carcinoma (RCC) treated with immune checkpoint inhibitors (ICI) [J].
Hahn, A. W. ;
Viscuse, P. V. ;
Pieretti, A. ;
Wiele, A. J. ;
Jonasch, E. ;
Gao, J. ;
Zurita, A. J. ;
Shah, A. Y. ;
Campbell, M. T. ;
Sharma, P. ;
Wood, C. G. ;
Tannir, N. M. ;
Karam, J. A. ;
Msaouel, P. .
ANNALS OF ONCOLOGY, 2021, 32 :S699-S700
[14]   Preoperative sorafenib (Sor) and cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC) [J].
Finelli, A. ;
Horgan, A. M. ;
Evans, A. ;
Kim, T. K. ;
Durrant, K. ;
Yap, S. ;
Cassol, C. A. ;
Dubinski, W. ;
Fleshner, N. ;
Jewett, M. A. S. ;
Joshua, A. M. ;
Sridhar, S. S. ;
Zlotta, A. ;
Knox, J. J. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[15]   External validation of a prediction model of survival after cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC). [J].
Bex, Axel ;
van Werkhoven, Erik D. ;
Noe, Allard ;
Karam, Jose A. ;
Matin, Surena F. ;
Margulis, Vitaly ;
Stewart, Grant ;
Staehler, Michael D. ;
Wood, Christopher G. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[16]   Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy [J].
Hahn, Andrew W. ;
Kotecha, Ritesh R. ;
Viscuse, Paul V. ;
Pieretti, Alberto C. ;
Wiele, Andrew J. ;
Jonasch, Eric ;
Lee, Chung-Han ;
Gao, Jianjun ;
Zurita, Amado J. ;
Shah, Amishi Y. ;
Campbell, Matthew T. ;
Sharma, Padmanee ;
Motzer, Robert J. ;
Russo, Paul ;
Wood, Christopher G. ;
Tannir, Nizar M. ;
Voss, Martin H. ;
Karam, Jose A. ;
Hakimi, A. Ari ;
Msaouel, Pavlos .
EUROPEAN UROLOGY FOCUS, 2023, 9 (05) :734-741
[17]   Salvage immune checkpoint inhibitor (ICI) plus tyrosine kinase inhibitor (TKI) combination therapy for metastatic renal cell carcinoma (mRCC). [J].
Parikh, Anish B. ;
Psutka, Sarah P. ;
Yang, Yuanquan ;
Collier, Katharine ;
Miah, Abdul ;
Li, Mingjia ;
Mori-Vogt, Sherry ;
Hinkley, Megan ;
Orcutt, Delaney ;
Trott, Elliott ;
Gross, Evan ;
Hussey, Duncan ;
Kramer, Joel ;
Oliva, Kaylee ;
Mortazavi, Amir ;
Monk, Paul ;
Folefac, Edmund ;
Clinton, Steven K. ;
Yin, Ming .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[18]   Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC). [J].
Zhu, Jason ;
Pabla, Sarabjot ;
Labriola, Matthew ;
Gupta, Rajan T. ;
McCall, Shannon ;
George, Daniel J. ;
Dressman, Devin ;
Glenn, Sean T. ;
Nesline, Mary ;
George, Saby ;
Morrison, Carl ;
Zhang, Tian .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
[19]   Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC). [J].
Zhu, Jason ;
Pabla, Sarabjot ;
Labriola, Matthew ;
Gupta, Rajan T. ;
McCall, Shannon ;
George, Daniel J. ;
Dressman, Devin ;
Glenn, Sean ;
Nesline, Mary ;
George, Saby ;
Morrison, Carl ;
Zhang, Tian .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
[20]   Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC). [J].
Zhu, Jason ;
Pabla, Sarabjot ;
Labriola, Matthew ;
Gupta, Rajan T. ;
McCall, Shannon ;
George, Daniel J. ;
Dressman, Devin ;
Glenn, Sean ;
George, Saby ;
Morrison, Carl ;
Zhang, Tian .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)